mazdaki

CERS - Dr. Benjamin the right add to the management team

做多
NASDAQ:CERS   Cerus Corporation
1
CERS lining up for the long term and with Dr. B on Board a long term purchase agreement with ARC is inevitable.
免责声明

这些信息和出版物并不意味着也不构成TradingView提供或认可的金融、投资、交易或其它类型的建议或背书。请在使用条款阅读更多信息。